Fluorescein Angiography With a Full-dose Versus a Half-dose of Intravenous Fluorescein
Clinical trial NCT03244982 · SUSPENDED
Trial details
- NCT number
- NCT03244982
- Sponsor
- Kresge Eye Institute
- Status
- SUSPENDED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-05
- Primary completion
- 2019-07-17
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.